Drugmakers Seeking Approval Under FDASIA Must Keep Manufacturing In Mind; FDA
Planning for manufacturing scale up is a critical step that biotech drug developers often overlook according to US FDA Commissioner, Margaret Hamburg.
Archives for March 20, 2013
Dispatches from Outsourcing in Clinical Trials East Coast, Philadelphia
Merck, Eisai Reap Savings from Off-Shoring, Outsourcing in China and India
Drugmakers Merck & Co and Eisai have both substantially cut internal data management costs through two unique off-shoring operations in China and India, respectively.
Novo Nordisk One Step Closer to Long-Acting Oral Insulin
Novo Nordisk says its long-acting oral insulin could become a lead product following the successful completion of an early-stage trial.
Outsourcing Storage Demand Drives Vindon Scientific Investments
Vindon says its investments in its Irish and Californian facilities come as pharma companies shift to outsourcing stability storage in order to save costs.
Quay adds Dedicated Ph III Packing and Distribution Capacity
Quay Pharma has added dedicated packaging distribution capacity to support Phase III trials in response to customer demand.
Private Equity Backs Micron Technologies Management Buyout
US-based particle engineering services frim Micron Technologies has been acquired in a private-equity backed management buyout.